Can you work or drive while taking Clozapine?

Clozapine is a CNS depressant that may cause sedation, drowsiness, and impaired coordination. It can affect driving ability and work capacity, particularly in safety-sensitive roles. Work capacity should be assessed on a case-by-case basis.

What should a case manager know about Clozapine?

Case managers should note that Clozapine is Moderate risk. It is a CNS depressant that may affect work capacity. Always check for drug interactions with other medications on the claim.

Antipsychotic | Moderate Risk

Clozapine (Clopine 200)

Q: What risk level is Clozapine for workers compensation claims?

Clozapine is classified as Moderate risk (4 risk points) by AllMeds. High-risk atypical antipsychotic with significant CNS depression, respiratory depression risk, and multiple serious adverse effects including agranulocytosis.

Q: What schedule is Clozapine in Australia?

Clozapine is classified as S4 under the Therapeutic Goods Administration (TGA) in Australia.

What to know about Clozapine — also sold as Clopine 200, Clozitor, Clozaril 25, Clopine 25, Clopine 50 and 4 more: uses, side effects, interactions, and safety considerations for people taking it or caring for someone who is.

Clozapine (brand names: Clopine 200, Clozitor, Clozaril 25, Clopine 25, Clopine 50 and 4 more) is classified as Moderate risk (4 risk points) by AllMeds. It is a S4 medication under the TGA in Australia. High-risk atypical antipsychotic with significant CNS depression, respiratory depression risk, and multiple serious adverse effects including agranulocytosis.

Key Takeaways

TGA Schedule: S4 in Australia
Risk level: Moderate (4 points)
CNS depressant: May cause sedation, impair driving, and affect work capacity
Respiratory depression risk: Requires monitoring, especially with other CNS depressants
Serotonergic: Risk of serotonin syndrome when combined with other serotonergic drugs
PBS listed: Subsidised under the Australian Pharmaceutical Benefits Scheme

Scheduling and Classification

Jurisdiction	Classification	Status
Australia (TGA)	S4	PBS listed

Risk Profile

Risk Level Moderate

Risk Points 4

CNS Depressant Yes

Respiratory Risk Yes

High-risk atypical antipsychotic with significant CNS depression, respiratory depression risk, and multiple serious adverse effects including agranulocytosis.

How Clozapine is regulated

Clozapine is overseen by medicines regulators in each country. The rules below explain how it's scheduled, what oversight applies, and what to discuss with your doctor or pharmacist before starting, changing, or stopping this medication.

Work capacity impact: As a CNS depressant, Clozapine may impair driving, operating machinery, and cognitive function. Work capacity certificates should reflect any medication-related restrictions.

Australia TGA / PBS / State Schemes

Classified as S4 under the Therapeutic Goods Administration (TGA).

Listed on the Pharmaceutical Benefits Scheme (PBS) for subsidised prescribing.

Check this medication against your full medication list

Run a full risk assessment including Clozapine interactions and compliance checks.

Allmeds AI Pharmacist scans interactions, schedules, and risk flags across your entire medication profile in minutes. Free for individuals; team plans for case managers, insurers, and schemes.

Try it free → Talk to Sales →

Important: This page is general health information, not personal medical advice. If you have questions about your medication — including starting it, stopping it, changing the dose, or combining it with something else — speak with your doctor or pharmacist. For an emergency or suspected overdose, call your local emergency number or poison information service immediately. Information is drawn from regulator and clinical guideline sources (TGA, FDA, MHRA, NICE, PBS, CDC); see our methodology for details.